Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
Nausea07.01.07.001--
Neck pain15.03.04.009--
Necrotising fasciitis15.03.03.004; 11.01.17.0020.013989%Not Available
Nephrotic syndrome20.05.01.0020.013989%
Nervous system disorder17.02.10.0010.020984%Not Available
Nervousness19.06.02.0030.027978%Not Available
Neuralgia17.02.07.0050.013989%
Neuropathic arthropathy15.01.01.007; 17.09.03.008--Not Available
Neuropathy peripheral17.09.03.003--Not Available
Neutropenia01.02.03.004--Not Available
Neutrophil count increased13.01.06.0110.034973%Not Available
Nitrogen balance negative13.13.01.010--Not Available
Nocardiosis11.02.04.0010.013989%Not Available
Oedema14.05.06.010; 08.01.07.0060.041967%Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Oesophagitis07.08.05.001--
Oliguria20.01.03.0040.003649%Not Available
Opportunistic infection11.01.08.0070.003649%Not Available
Optic neuritis06.04.08.002; 17.04.05.001; 10.04.10.0020.013989%Not Available
Oral discomfort07.05.05.0010.013989%Not Available
Osteonecrosis24.04.05.004; 15.02.04.0070.111913%
Osteoporosis15.02.03.002; 14.04.04.0020.005474%
Oxygen saturation decreased13.02.01.0040.146886%Not Available
Pain08.01.08.0040.181859%
Pain in extremity15.03.04.010--
Pain of skin23.03.03.0030.020984%
Pallor24.03.04.001; 23.03.03.031; 08.01.03.0320.083935%Not Available
Palmar erythema23.03.06.0100.013989%Not Available
Palmar-plantar erythrodysaesthesia syndrome17.02.07.009; 23.07.04.001--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 17 Pages